Genç E, Hoşal A S, Gedikoğlu G, Ozyar E, Sözeri B
Departments of Otolaryngology-Head and Neck Surgery, Pathology, and Radiation Oncology, Hacettepe University Medical Faculty, Anakra, Turkey.
Otolaryngol Head Neck Surg. 2000 Jun;122(6):868-73. doi: 10.1016/S0194-59980070016-7.
In this study the prognostic importance of p53, proliferating cell nuclear antigen (PCNA), and Ki-67 expression was analyzed along with the clinical parameters in 35 consecutive patients with undifferentiated nasopharyngeal carcinomas. Immunohistochemistry was used to detect p53, PCNA, and Ki-67 staining. Among the clinical findings, stage IV disease (P = 0.01), cranial nerve paralysis (P = 0.02), and lymph node metastasis (P = 0.06) were associated with shorter survival. The p53 positivity correlated with the presence of lymph nodes, but it was not a significant factor to predict the outcome. PCNA expression was not found to be a prognostic indicator. On the other hand, the proliferative value of Ki-67 staining was suggestive of prognosis. A proliferation index of Ki-67 less than 10% indicated longer survival (P = 0.03). There was no correlation between Ki-67 staining and PCNA index. As a result, the prognostic value of Ki-67 may alert the physician to more aggressive and adjuvant treatment modalities.
在本研究中,我们分析了35例连续的未分化鼻咽癌患者中p53、增殖细胞核抗原(PCNA)和Ki-67表达的预后重要性,并结合了临床参数。采用免疫组织化学法检测p53、PCNA和Ki-67染色。在临床发现中,IV期疾病(P = 0.01)、颅神经麻痹(P = 0.02)和淋巴结转移(P = 0.06)与较短的生存期相关。p53阳性与淋巴结的存在相关,但它不是预测预后的重要因素。未发现PCNA表达是一个预后指标。另一方面,Ki-67染色的增殖值提示预后。Ki-67增殖指数小于10%表明生存期较长(P = 0.03)。Ki-67染色与PCNA指数之间无相关性。因此,Ki-67的预后价值可能提醒医生采用更积极的辅助治疗方式。